New England Journal of Medicine in April 2020 described how some COVID-19 patients from northern Italy had been found to have symptoms resembling those of GBS.
In these patients, the GBS symptoms emerged a few days after COVID-19 symptom onset and included lower limb weakness, a tingling sensation, facial paralysis and impaired limb coordination. Providing immunoglobulin therapy strengthened these patients’ immune response and helped them recover slowly yet steadily.
Many other case studies and reports from around the world have also indicated that patients of COVID-19 are developing GBS symptoms in rare cases.
Another study published in
Neurologia in October 2020 suggests that not only do coronavirus